Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect
ACS Publications. Most Trusted. Most Cited. Most Read
Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models
My Activity

Figure 1Loading Img
    Article

    Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models
    Click to copy article linkArticle link copied!

    • Elizabeth N. Kaweesa
      Elizabeth N. Kaweesa
      Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60607, United States
    • Jaqueline M. Bazioli
      Jaqueline M. Bazioli
      Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60607, United States
    • Herma C. Pierre
      Herma C. Pierre
      Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States
    • Daniel D. Lantvit
      Daniel D. Lantvit
      Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60607, United States
    • Samuel K. Kulp
      Samuel K. Kulp
      Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, Ohio 43210, United States
    • Kasey L. Hill
      Kasey L. Hill
      Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States
    • Mitch A. Phelps
      Mitch A. Phelps
      Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States
    • Christopher C. Coss
      Christopher C. Coss
      Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States
    • James R. Fuchs
      James R. Fuchs
      Division of Medicinal Chemistry and Pharmacognosy, The Ohio State University, Columbus, Ohio 43210, United States
    • Cedric J. Pearce
      Cedric J. Pearce
      Mycosynthetix, Inc., Hillsborough, North Carolina 27278, United States
    • Nicholas H. Oberlies
      Nicholas H. Oberlies
      Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States
    • Joanna E. Burdette*
      Joanna E. Burdette
      Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60607, United States
      *Email: [email protected]. Phone: 312-996-6153.
    Other Access OptionsSupporting Information (1)

    Molecular Pharmaceutics

    Cite this: Mol. Pharmaceutics 2023, 20, 6, 3049–3059
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.molpharmaceut.3c00069
    Published May 8, 2023
    Copyright © 2023 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    Verticillins are epipolythiodioxopiperazine alkaloids isolated from a fungus with nanomolar anti-tumor activity in high-grade serous ovarian cancer (HGSOC). HGSOC is the fifth leading cause of death in women, and natural products continue to be an inspiration for new drug entities to help tackle chemoresistance. Verticillin D was recently found in a new fungal strain and compared to verticillin A. Both compounds exhibited nanomolar cytotoxic activity against OVCAR4 and OVCAR8 HGSOC cell lines, significantly reduced 2D foci and 3D spheroids, and induced apoptosis. In addition, verticillin A and verticillin D reduced tumor burden in vivo using OVCAR8 xenografts in the peritoneal space as a model. Unfortunately, mice treated with verticillin D displayed signs of liver toxicity. Tolerability studies to optimize verticillin A formulation for in vivo delivery were performed and compared to a semi-synthetic succinate version of verticillin A to monitor bioavailability in athymic nude females. Formulation of verticillins achieved tolerable drug delivery. Thus, formulation studies are effective at improving tolerability and demonstrating efficacy for verticillins.

    Copyright © 2023 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.3c00069.

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!

    This article has not yet been cited by other publications.

    Molecular Pharmaceutics

    Cite this: Mol. Pharmaceutics 2023, 20, 6, 3049–3059
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.molpharmaceut.3c00069
    Published May 8, 2023
    Copyright © 2023 American Chemical Society

    Article Views

    609

    Altmetric

    -

    Citations

    -
    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.